相关实验视频

Updated: Jul 27, 2026

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.2K

在患有三阴性乳腺癌的患者遗传遗传检测的差异

Shruti Gupta1, Jade E Jones2, Demetria Smith-Graziani2

  • 1Department of Medicine, Emory University School of Medicine, Atlanta, GA.

Clinical breast cancer
|October 30, 2024
PubMed
概括

遗传基因检测对于三阴性乳腺癌 (TNBC) 患者至关重要,特别是那些 BRCA1 突变患者. 消除障碍可以改善高风险个体获得必要的预防和治疗策略的机会.

关键词:
这就是BRCA1的原因.这就是BRCA2的原因.在健康方面存在差异.降低风险 降低风险查检查 查检查 查检查

更多相关视频

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers11:34

Building Up a High-throughput Screening Platform to Assess the Heterogeneity of HER2 Gene Amplification in Breast Cancers

Published on: December 5, 2017

12.6K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

628

相关概念视频

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...